Vivalyx
Signal active
Organization
Contact Information
Overview
Vivalyx Omnisol will be a process- and cost-effective one-stop solution for all preservation applications, allowing NMP without the use of blood or human products.
About
Industries
Health Care, Medical, Manufacturing
Founded
2022
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Vivalyx headquartered in Europe, operates in the Health Care, Medical, Manufacturing sector. The company focuses on Health Care and has secured $266.5M in funding across 36 round(s). With a team of 1-10 employees, Vivalyx is actively contributing to advancements in Health Care. Their latest funding round, Seed Round - Vivalyx, raised $5.8M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
3
Investors
7
Lead Investors
0
Total Funding Amount
$7.4M
Details
2
Vivalyx has raised a total of $7.4M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 1.6M | ||
| 2024 | Seed | 5.8M |
Investors
Vivalyx is funded by 13 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Brightlands Venture Partners | - | FUNDING ROUND - Brightlands Venture Partners | 5.8M |
| Springboard Health Angels | - | FUNDING ROUND - Springboard Health Angels | 5.8M |
| Vivalyx | - | FUNDING ROUND - Vivalyx | 5.8M |
| Yoni Goldwasser | - | FUNDING ROUND - Yoni Goldwasser | 5.8M |
Recent Activity
There is no recent news or activity for this profile.